Medical News

RSS

WebMD completes optional redemption of 1.75% Convertible Subordinated Notes due 2023

WebMD Health Corp. has completed the optional redemption of its 1.75% Convertible Subordinated Notes due June 15, 2023. When the redemption was announced last month, approximately $188 million in aggregate principal amount of the 1.75% Notes were outstanding.

22 Jun 2010

Metabolex signs global development and license agreement with OMJPI

Metabolex, Inc. announced today that they have entered into a global development and license agreement with Ortho-McNeil-Janssen Pharmaceuticals, Inc. to further develop and discover compounds for the treatment of type 2 diabetes and other disorders. Under the agreement, OMJPI will receive an exclusive worldwide license to develop, manufacture, and commercialize several Metabolex programs that are currently at the preclinical stage.

22 Jun 2010

Aesculap Implant Systems introduces S4 MIS Cannulated Pedicle Screw Spine Fusion System

Aesculap Implant Systems, LLC is pleased to announce the launch of the S4® MIS (Minimally Invasive Solutions) Cannulated Pedicle Screw Spine Fusion System.

22 Jun 2010

Baxano closes $30M Series C round of venture funding

Baxano, Inc. today announced the closing of a $30 million Series C round of venture funding, led by new investor CMEA Capital. Funds were also contributed by new investors Kaiser Permanente Ventures and Affinity Capital Management and existing investors Prospect Venture Partners, Three Arch Partners, and Kearny Venture Partners.

22 Jun 2010

Scientists complete comparative analysis of bacterial communities living in human nose, throat

Scientists have completed the most comprehensive comparative analysis to date of bacterial communities inhabiting the human nose and throat, which could provide new insights into why some individuals become colonized with pathogens while others do not. They release their findings today in mBio- the online open-access journal published by the American Society for Microbiology.

22 Jun 2010

Teens to call upon Congress to fund drug research for rare diseases

Teens from across the United States whose siblings have cystic fibrosis will press their elected officials in Washington, D.C., June 24, to fund drug research and increase access to clinical trials for those with rare diseases.

22 Jun 2010

Fructose makes cells mature into fat cells in belly fat, study finds

Fructose, the sugar widely used as high-fructose corn syrup in soft drinks and processed foods, often gets some of the blame for the widespread rise in obesity. Now a laboratory study has found that when fructose is present as children's fat cells mature, it makes more of these cells mature into fat cells in belly fat and less able to respond to insulin in both belly fat and fat located below the skin.

22 Jun 2010

International team obtains genome sequence of human body louse

An international team has obtained the genome sequence of the human body louse (Pediculus humanus humanus), a parasite that feeds on the blood of its host and a vector of pathogens that cause diseases such as epidemic typhus, relapsing fever and trench fever.

22 Jun 2010

Three leading scientists gather to discuss Improved Strategies for Pre-clinical Cardiac Testing

Three leading scientists in the field of cardiac safety in pre-clinical drug development are gathering to discuss Improved Strategies for Pre-clinical Cardiac Testing in a free webinar on June 23 at 11:00 a.m. EDT, sponsored by the Drug Safety Council.

22 Jun 2010

Spectranetics to settle securities class action litigation

The Spectranetics Corporation today announced that it has agreed in principle to settle both the securities class action litigation pending against the company and certain of its current and former officers and directors and the stockholder derivative case naming the company as a nominal defendant and certain of its current and former officers and directors as defendants.

22 Jun 2010

Beneficial effects of LifeVantage's Protandim on DMD mouse model published in Journal of Dietary Supplements

LifeVantage Corporation, the maker of Protandim®, a patented, science-based solution to oxidative stress, announced today that a peer-reviewed manuscript was published in the Journal of Dietary Supplements examining the beneficial effects of Protandim® on a mouse model of Duchenne Muscular Dystrophy (DMD), an X-linked inherited disease affecting one in 3,500 males.

22 Jun 2010

USPTO issues patent related to Derma Sciences' MEDIHONEY Calcium Alginate Dressing

Derma Sciences, Inc., a medical device and pharmaceutical company focused on advanced wound care, announces that the U.S. Patent and Trademark Office has issued patent No. 7,714,183 related to the Company's MEDIHONEY Calcium Alginate Dressing.

22 Jun 2010

MusclePharm commences trading on OTCBB under ticker symbol 'MSLP'

MusclePharm® Corporation, the fastest-growing brand in the sports nutrition supplement industry, announces that its common stock is now trading on the OTC Bulletin Board (OTCBB) under the ticker symbol "MSLP."

22 Jun 2010

Medicity receives high ratings in IDC Health Insights' HIE vendor evaluation

A recent study by IDC Health Insights that evaluated HIE vendors based on fit to market needs and ability to provide clients with a positive ownership experience placed Medicity as a leading vendor in the HIE technologies market.

22 Jun 2010

Nature Rocks, American Heart Association encourage increased physical activity among all Americans

Today Nature Rocks, a national program created to inspire and empower parents to take their families to play, explore and enjoy quality time in nature, announced a collaboration with the American Heart Association's Start! Initiative. Start! encourages increased physical activity among all Americans, emphasizing walking because it's easy, free and has the lowest dropout rate of any form of activity.

22 Jun 2010

Cardiogenesis' shares quoted on newly launched OTCQB market

Cardiogenesis Corporation today announced that its shares are now being quoted on the newly launched OTCQB market. Launched in April 2010, the OTCQB is a new market tier for OTC-traded U.S. companies that are registered and reporting with the Securities and Exchange Commission.

22 Jun 2010

Pancreatic Cancer Action Network hosts fourth annual Pancreatic Cancer Advocacy Day

The Pancreatic Cancer Action Network today hosts its fourth annual Pancreatic Cancer Advocacy Day in Washington, D.C. Nearly 500 advocates, including patients, survivors and loved ones, from across the United States will meet with members of Congress to call for congressional action to ensure progress is made against the fourth leading cause of cancer death in our country by co-sponsoring the Pancreatic Cancer Research and Education Act.

22 Jun 2010

NCI awards GeneGo Phase II SBIR grant for development of MetaMiner(Oncology) platform

GeneGo, Inc., a leading provider of databases, software and services in systems biology and chemistry, announced today that they were awarded with a Phase II SBIR grant from the National Cancer Institute (NCI) for further development of an analytical platform for translational research and data analysis in oncology.

22 Jun 2010

Pro-Pharmaceuticals receives first purchase order for DAVANAT from PROCAPS

Pro-Pharmaceuticals, Inc., the leading developer of therapeutics that target Galectin receptors to treat cancer and fibrosis, today announced it has received its first purchase order for DAVANAT from PROCAPS S.A., a large, international pharmaceutical company based in Barranquilla, Colombia. Pro-Pharmaceuticals has received a purchase order for $200,000 which will be the upfront payment for this first shipment of DAVANAT.

22 Jun 2010

Aurora Dedicated Breast MRI System installed at Ruijin Hospital, China

Aurora Imaging Technology, Inc. today announced the installation of the Aurora® Dedicated Breast MRI System in China at the world-renowned Ruijin Hospital located in Shanghai, the teaching hospital for China's top-tiered Jiao Tong University Medical School. The installation marks the first Aurora System in China.

22 Jun 2010

Medical News

WebMD completes optional redemption of 1.75% Convertible Subordinated Notes due 2023

Metabolex signs global development and license agreement with OMJPI

Aesculap Implant Systems introduces S4 MIS Cannulated Pedicle Screw Spine Fusion System

Baxano closes $30M Series C round of venture funding

Scientists complete comparative analysis of bacterial communities living in human nose, throat

Teens to call upon Congress to fund drug research for rare diseases

Fructose makes cells mature into fat cells in belly fat, study finds

International team obtains genome sequence of human body louse

Three leading scientists gather to discuss Improved Strategies for Pre-clinical Cardiac Testing

Spectranetics to settle securities class action litigation

Beneficial effects of LifeVantage's Protandim on DMD mouse model published in Journal of Dietary Supplements

USPTO issues patent related to Derma Sciences' MEDIHONEY Calcium Alginate Dressing

MusclePharm commences trading on OTCBB under ticker symbol 'MSLP'

Medicity receives high ratings in IDC Health Insights' HIE vendor evaluation

Nature Rocks, American Heart Association encourage increased physical activity among all Americans

Cardiogenesis' shares quoted on newly launched OTCQB market

Pancreatic Cancer Action Network hosts fourth annual Pancreatic Cancer Advocacy Day

NCI awards GeneGo Phase II SBIR grant for development of MetaMiner(Oncology) platform

Pro-Pharmaceuticals receives first purchase order for DAVANAT from PROCAPS

Aurora Dedicated Breast MRI System installed at Ruijin Hospital, China

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News